Sandoz Group AG (SWX:SDZ)
Switzerland
· Delayed Price · Currency is CHF 41.76
-0.21 (-0.50%)
Feb 21, 2025, 5:31 PM CET
Sandoz Group AG Employees
Sandoz Group AG had 22,633 employees as of December 31, 2023. The number of employees increased by 895 or 4.12% compared to the previous year.
Employees
22,633
Change (1Y)
895
Growth (1Y)
4.12%
Revenue / Employee
401.44K CHF
Profits / Employee
-317.62 CHF
Market Cap
18.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,686 |
| Alcon | 25,315 |
| Galderma Group AG | 6,545 |
| Straumann Holding AG | 11,109 |
| Sonova Holding AG | 18,151 |
| Ypsomed Holding AG | 2,296 |
Sandoz Group AG News
- 6 weeks ago - Intra-Cellular Therapies Stock Soars 19% After Securing Major Patent Victory Over Sandoz - GuruFocus
- 6 weeks ago - Intra-Cellular settles Caplyta patent dispute with Sandoz - Seeking Alpha
- 6 weeks ago - Intra-Cellular Therapies Inc (ITCI) Announces Settlement with Sandoz Over CAPLYTA Patent Litigation - GuruFocus
- 2 months ago - Caplin Point gets USFDA approval for eye drops – Difluprednate Ophthalmic Emulsion - Business Upturn
- 2 months ago - Sandoz Charts Path to Swift Generic Ozempic Launch in Canada - Financial Post
- 2 months ago - Sandoz Charts Path to Swift Generic Ozempic Launch in Canada - BNN Bloomberg
- 3 months ago - Glenmark Pharmaceuticals shares in focus as company launches Travoprost Ophthalmic Solution in U.S. - Business Upturn
- 3 months ago - Glenmark Pharmaceuticals USA launches Travoprost Ophthalmic Solution USP - Business Upturn